‹ All headlines
ScienceDaily Health Misfolded insulin may be quietly driving diabetes
ScienceDaily Health A single sauna session sends immune cells surging
ScienceDaily Health Why losing weight may not be enough to prevent type 2 diabetes
ScienceDaily Health WHO: Integration, innovation and community leadership key to ending HIV, hepatitis and STIs
WHO Why the same DNA damage causes cancer in some people but not others
ScienceDaily Health
ScienceDaily Health
Ozempic and Mounjaro linked to a surprising hair loss risk
A large study suggests that GLP-1 drugs including Ozempic and Mounjaro may slightly increase the risk of hair loss in people with type 2 diabetes. Compared with two other common classes of diabetes medications, GLP-1 users had a significantly higher rate of alopecia, though the absolute risk was still low. The hair loss was mainly non-scarring, which means it may be reversible.
Related headlines
Exercise may not help hip arthritis as much as patients expectScienceDaily Health Misfolded insulin may be quietly driving diabetes
ScienceDaily Health A single sauna session sends immune cells surging
ScienceDaily Health Why losing weight may not be enough to prevent type 2 diabetes
ScienceDaily Health WHO: Integration, innovation and community leadership key to ending HIV, hepatitis and STIs
WHO Why the same DNA damage causes cancer in some people but not others
ScienceDaily Health
Get the EPELCON App v3.6.0
Invest, Learn & Earn on the go